MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 94 filers reported holding MERUS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,418,198 | +14.5% | 3,876,938 | +27.9% | 2.01% | +18.2% |
Q2 2023 | $79,830,928 | +82.3% | 3,031,938 | +27.4% | 1.70% | +74.6% |
Q1 2023 | $43,800,059 | +18.9% | 2,380,438 | 0.0% | 0.98% | +28.1% |
Q4 2022 | $36,825,376 | -27.1% | 2,380,438 | -5.6% | 0.76% | -24.2% |
Q3 2022 | $50,507,000 | +12.3% | 2,521,553 | +27.0% | 1.00% | +8.4% |
Q2 2022 | $44,961,000 | +289.1% | 1,985,924 | +354.4% | 0.93% | +259.3% |
Q1 2022 | $11,554,000 | -16.9% | 437,000 | 0.0% | 0.26% | -11.3% |
Q4 2021 | $13,897,000 | – | 437,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |